“Efficacy of Generic Bortezomib Used As a Part of CyBorD Regimen to Achieve Complete Response in Multiple Myeloma”. 2019. Innovative Journal of Medical and Health Sciences 9 (1): 247-51. https://doi.org/10.15520/ijmhs.v9i1.2431.